• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

6TH EDITION OF THE LUCE REPORT: SURVIVORSHIP AND QUALITY OF LIFE OF PEOPLE IMPACTED BY LUNG CANCER IN EUROPE

This is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness regarding the main […]

OPEN LETTER: INCREASING THE EARLY DIAGNOSIS OF LUNG CANCER IN EUROPE: AN ESSENTIAL MILESTONE TO TACKLE THE BIGGEST CANCER KILLER

Dear MEPs, The European Respiratory Society (ERS), together with the undersigned 27 organisations, urges you to take into account the […]

IASCL LANGUAGE GUIDE

The International Association for the Study of Lung Cancer released its first-ever Language Guide to promote best practices in all […]

LUCE WEBINAR: STRENGHTENING THE LUNG CANCER PATIENT VOICE IN HEALTH POLICY AND REGULATORY DECISION

As part of its Educational & Capacity Building Programme, Lung Cancer Europe (LuCE) ran an introductory session on Strengthening the Lung Cancer Patient Voice […]

INVESTING IN THE FUTURE: IMPROVING CANCER BIOMARKER TESTING AND CANCER DIAGNOSIS FOR SUSTAINABLE HEALTHCARE

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by […]

LIVING WITH LUNG CANCER: SURVIVORSHIP AND QUALITY OF LIFE – SURVEY FOR PATIENTS AND CAREGIVERS

Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such […]